ChartRow logo
Share this page
PTGX
$128.75-5.71%
as of close, Oct 16, 2026
☾ AH $128.75 -5.71%
Protagonist Therapeutics Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.01%US Stock Market 0.01%Russell 3000 0.010%
PeersMRNALLYMDTUNHJNJTMO

Protagonist Therapeutics Inc. total returns by year (including dividends)

As of market close, Oct 16, 2026

Protagonist Therapeutics Inc. total returns by year (2017–2026)#

Protagonist Therapeutics Inc. annual returns by year
YearTotal return
2026YTD
+47.4%
2025
+126.3%
2024
+68.3%
2023
+110.2%
2022
-68.1%
2021
+69.6%
2020
+186.0%
2019
+4.8%
2018
-67.6%
2017
-5.4%
Annualized
+26.4%
2017–2026
Average year
+47.1%
9 full years
Best year
+186.0%
2020
Worst year
-68.1%
2022
Positive years
6/9
67% up

Total return by period#

Annual

Methodology#

Total returns, dividends reinvested, measured on PTGX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.

FAQ#

What is Protagonist Therapeutics Inc.'s average annual return?
Since 2017, Protagonist Therapeutics Inc. (PTGX) has returned about 26.4% a year (the compound annual growth rate) and an average calendar-year return of 47.1%.
What were Protagonist Therapeutics Inc.'s best and worst years?
Over 2017–2026, the best year was 2020 (+186.0%) and the worst was 2022 (-68.1%).
How often is Protagonist Therapeutics Inc. up in a year?
6 of the 9 full years since 2017 were positive — about 67% of the time.

More on Protagonist Therapeutics Inc.